Regeneron

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Regeneron 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About REGN

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. 

CEO
Leonard S. Schleifer
CEOLeonard S. Schleifer
Employees
15,410
Employees15,410
Headquarters
Tarrytown, New York
HeadquartersTarrytown, New York
Founded
1988
Founded1988
Employees
15,410
Employees15,410

REGN Key Statistics

Market cap
79.16B
Market cap79.16B
Price-Earnings ratio
18.05
Price-Earnings ratio18.05
Dividend yield
0.48%
Dividend yield0.48%
Average volume
640.35K
Average volume640.35K
High today
$771.48
High today$771.48
Low today
$739.18
Low today$739.18
Open price
$771.48
Open price$771.48
Volume
751.46K
Volume751.46K
52 Week high
$821.11
52 Week high$821.11
52 Week low
$476.49
52 Week low$476.49

Stock Snapshot

Regeneron(REGN) stock is priced at $749.36, giving the company a market capitalization of 79.16B. It carries a P/E multiple of 18.05 and pays a dividend yield of 47.8%.

During the trading session on 2026-04-12, Regeneron(REGN) shares reached a daily high of $771.48 and a low of $739.18. At a current price of $749.36, the stock is +1.4% higher than the low and still -2.9% under the high.

Trading activity shows a volume of 751.46K, compared to an average daily volume of 640.35K.

The stock's 52-week range extends from a low of $476.49 to a high of $821.11.

The stock's 52-week range extends from a low of $476.49 to a high of $821.11.

REGN News

TipRanks 4d
Regeneron price target lowered to $921 from $925 at Bernstein

Bernstein lowered the firm’s price target on Regeneron (REGN) to $921 from $925 and keeps an Outperform rating on the shares. The firm notes the company’s long-...

Analyst ratings

77%

of 31 ratings
Buy
77.4%
Hold
22.6%
Sell
0%

People also own

Based on the portfolios of people who own REGN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.